Literature DB >> 19746915

A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.

Insik Jeon1, Dongjoo Lee, Isaac J Krauss, Samuel J Danishefsky.   

Abstract

Fully synthetic, carbohydrate-based antitumor vaccine candidates have been synthesized in highly clustered modes. Multiple copies of tumor-associated carbohydrate antigens, Tn and STn, were assembled on a single cyclic peptide scaffold in a highly convergent manner. Ring-closing metathesis-mediated incorporation of an internal cross-linker was also demonstrated. In particular, this rigidified cross-linked construct would enhance a cluster-recognizing antibody response by retaining an appropriate distance between glycans attached to the peptide platform. Details of the design and synthesis of highly clustered antigens are described herein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19746915      PMCID: PMC2758925          DOI: 10.1021/ja9052625

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  56 in total

1.  Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.

Authors:  S K Kim; G Ragupathi; S Cappello; E Kagan; P O Livingston
Journal:  Vaccine       Date:  2000-10-15       Impact factor: 3.641

2.  Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.

Authors:  V Kudryashov; P W Glunz; L J Williams; S Hintermann; S J Danishefsky; K O Lloyd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial.

Authors:  T Gilewski; G Ragupathi; S Bhuta; L J Williams; C Musselli; X F Zhang; W G Bornmann; M Spassova; K P Bencsath; K S Panageas; J Chin; C A Hudis; L Norton; A N Houghton; P O Livingston; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.

Authors:  D J Marciani; J B Press; R C Reynolds; A K Pathak; V Pathak; L E Gundy; J T Farmer; M S Koratich; R D May
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

5.  Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.

Authors:  S K Kim; G Ragupathi; C Musselli; S J Choi; Y S Park; P O Livingston
Journal:  Vaccine       Date:  1999-11-12       Impact factor: 3.641

6.  Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens.

Authors:  J R Allen; C R Harris; S J Danishefsky
Journal:  J Am Chem Soc       Date:  2001-03-07       Impact factor: 15.419

7.  Ring-closing metathesis of olefinic peptides: design, synthesis, and structural characterization of macrocyclic helical peptides.

Authors:  H E Blackwell; J D Sadowsky; R J Howard; J N Sampson; J A Chao; W E Steinmetz; D J O'Leary; R H Grubbs
Journal:  J Org Chem       Date:  2001-08-10       Impact factor: 4.354

8.  Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.

Authors:  P J Sabbatini; V Kudryashov; G Ragupathi; S J Danishefsky; P O Livingston; W Bornmann; M Spassova; A Zatorski; D Spriggs; C Aghajanian; S Soignet; M Peyton; C O'Flaherty; J Curtin; K O Lloyd
Journal:  Int J Cancer       Date:  2000-07-01       Impact factor: 7.396

9.  From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-03       Impact factor: 15.336

10.  Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

Authors:  S F Slovin; G Ragupathi; S Adluri; G Ungers; K Terry; S Kim; M Spassova; W G Bornmann; M Fazzari; L Dantis; K Olkiewicz; K O Lloyd; P O Livingston; S J Danishefsky; H I Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  9 in total

1.  Sortase A-catalyzed peptide cyclization for the synthesis of macrocyclic peptides and glycopeptides.

Authors:  Zhimeng Wu; Xueqing Guo; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2011-07-08       Impact factor: 6.222

2.  Scalable synthesis of Fmoc-protected GalNAc-threonine amino acid and T(N) antigen via nickel catalysis.

Authors:  Fei Yu; Matthew S McConnell; Hien M Nguyen
Journal:  Org Lett       Date:  2015-04-08       Impact factor: 6.005

3.  An Advanced 'clickECM' That Can be Modified by the Inverse-Electron-Demand Diels-Alder Reaction.

Authors:  Svenja Nellinger; Mareike A Rapp; Alexander Southan; Valentin Wittmann; Petra J Kluger
Journal:  Chembiochem       Date:  2021-08-17       Impact factor: 3.461

4.  Carbohydrate-Based Polymers for Immune Modulation.

Authors:  Kenneth Lin; Andrea M Kasko
Journal:  ACS Macro Lett       Date:  2014-06-17       Impact factor: 6.903

5.  Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.

Authors:  Carlo Pifferi; Baptiste Thomas; David Goyard; Nathalie Berthet; Olivier Renaudet
Journal:  Chemistry       Date:  2017-10-25       Impact factor: 5.236

6.  A Tetra-Orthogonal Strategy for the Efficient Synthesis of Scaffolds Based on Cyclic Peptides.

Authors:  Nitin Jain; Simon H Friedman
Journal:  Int J Pept Res Ther       Date:  2017-11-01       Impact factor: 1.931

Review 7.  Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification.

Authors:  Zhi-Hua Huang; Zhan-Yi Sun; Yue Gao; Pu-Guang Chen; Yan-Fang Liu; Yong-Xiang Chen; Yan-Mei Li
Journal:  Vaccines (Basel)       Date:  2014-07-15

8.  Synthesis of homo- and heteromultivalent carbohydrate-functionalized oligo(amidoamines) using novel glyco-building blocks.

Authors:  Felix Wojcik; Sinaida Lel; Alexander G O'Brien; Peter H Seeberger; Laura Hartmann
Journal:  Beilstein J Org Chem       Date:  2013-11-07       Impact factor: 2.883

9.  'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.

Authors:  Alison L Parry; Natasha A Clemson; James Ellis; Stefan S R Bernhard; Benjamin G Davis; Neil R Cameron
Journal:  J Am Chem Soc       Date:  2013-06-17       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.